Use este identificador para citar ou linkar para este item:
Título: Azilsartan reduced TNF-α and IL-1β levels, increased IL-10 Levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis model
Autor(es): Araújo, Aurigena Antunes de
Varela, Hugo
Medeiros, Caroline Addison Carvalho Xavier de
Brito, Gerly Anne de Castro
Lima, Kênio Costa de
Moura, Ligia Moreno de
Araújo Júnior, Raimundo Fernandes de
Palavras-chave: Mucosite
Data do documento: Fev-2015
Editor: Plos One
Citação: ARAÚJO, A. A. ; VARELA, H. ; MEDEIROS, C. A. C. X. ; BRITO, G. A. C. ; LIMA, K. C. ; MOURA, L. M. ; ARAÚJO JÚNIOR, R. F. (2015)
Abstract: Oral mucositis (OM) is a common complication of treatments for head and neck cancer, particularly radiotherapy with or without chemotherapy. OM is characterised by oral erythema, ulceration, and pain. The aim of this study was to evaluate the effect of azilsartan (AZT), an angiotensin II receptor antagonist, on 5-fluorouracil (5-FU)-induced oral mucositis (OM) in Syrian hamsters. OM was induced by the intraperitoneal administration of 5-FU on experimental days 1 (60mg/Kg) and 2 (40mg/Kg). Animals were pretreated with oral AZT (1, 5, or 10 mg/kg) or vehicle 30 min before 5-FU injection and daily until day 10. Experimental treatment protocols were approved by the Animal Ethics Committee Use/CEUA (Number 28/2012) of the UFRN. Macroscopic analysis and cheek pouch samples were removed for histopathologic analysis. Myeloperoxidase (MPO), Malonyldialdehyde (MDA), interleukin-1 beta (IL-1β), interleukin-10 (IL-10), and tumour necrosis factor-alpha (TNF-α) were analysed by Enzyme Linked Immuno Sorbent Assay (ELISA). Vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), keratinocyte growth factor (KGF), and transforming growth factor (TGF)-α were measured by immunohistochemistry. Analysis of variance followed by Bonferroni’s test was used to calculate the means of intergroup differences (p 0.05). Treatment with 1 mg/kg AZT reduced levels MPO (p<0.01), MDA (p<0.5) and histological inflammatory cell infiltration, and increased the presence of granulation tissue. AZT treatment at 1 mg/kg reduced the TNF-α (p<0.05) and IL-1β (p<0.05) levels, increased the cheek pouch levels of IL-10 (p<0.01), and upregulated VEGF, FGF, KGF, and TGF-α. Administration of AZT at higher doses (5 and 10 mg/kg) did not significantly reverse the OM. AZT at a dose of 1 mg/kg prevented the mucosal damage and inflammation associated with 5-FU-induced OM, increasing granulation and tissue repair.
Descrição: ARAÚJO, Aurigena Antunes de ; VARELA, Hugo ; MEDEIROS, Caroline Addison Carvalho Xavier de ; BRITO, Gerly Anne de Castro ; LIMA, Kênio Costa de ; MOURA, Ligia Moreno de ; ARAÚJO JÚNIOR, Raimundo Fernandes de. Azilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis mode. Plos One, v. 10, p. 1-16, fev. 2015.
Aparece nas coleções:DFIFA - Artigos publicados em revista científica

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
2015_art_cacxmedeiros.pdf15,97 MBAdobe PDFVisualizar/Abrir

Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.